CRESCIOLI, CLARA
 Distribuzione geografica
Continente #
NA - Nord America 2.161
EU - Europa 1.208
AS - Asia 162
AF - Africa 7
Totale 3.538
Nazione #
US - Stati Uniti d'America 2.159
PL - Polonia 452
SE - Svezia 214
IE - Irlanda 145
IT - Italia 112
UA - Ucraina 99
HK - Hong Kong 98
DE - Germania 60
FI - Finlandia 38
CN - Cina 29
GB - Regno Unito 26
CH - Svizzera 24
JO - Giordania 15
FR - Francia 11
AT - Austria 10
BE - Belgio 8
VN - Vietnam 8
NL - Olanda 5
SC - Seychelles 5
TR - Turchia 5
SG - Singapore 4
ES - Italia 3
IN - India 3
CA - Canada 2
MU - Mauritius 2
MK - Macedonia 1
Totale 3.538
Città #
Warsaw 452
Fairfield 346
Chandler 184
Ashburn 176
Woodbridge 175
Jacksonville 170
Seattle 167
Houston 148
Dublin 145
Cambridge 142
Wilmington 116
Ann Arbor 90
Hong Kong 72
Altamura 48
Princeton 41
Lawrence 39
Boston 31
Boardman 26
Bern 24
San Diego 23
Buffalo 20
Medford 17
Beijing 13
New York 10
Norwalk 10
Vienna 10
Auburn Hills 8
Brussels 8
Dong Ket 8
Florence 8
Shanghai 8
West Jordan 8
Andover 7
Falls Church 7
Hillsboro 7
Izmir 5
Milan 5
Frankfurt Am Main 4
Los Angeles 4
Singapore 4
Verona 4
Barcelona 3
Phoenix 3
Redwood City 3
Rome 3
Avigliano 2
Chicago 2
Dearborn 2
Djursholm 2
Pune 2
Sagliano Micca 2
Schio 2
Toronto 2
Västerås 2
Brooklyn 1
Changsha 1
Fuzhou 1
Groningen 1
Guangzhou 1
Hefei 1
Helsinki 1
Jinan 1
Kilburn 1
London 1
Nanjing 1
Napoli 1
New Bedfont 1
Old Bridge 1
Salerno 1
San Leo 1
Scandicci 1
Xian 1
Zhengzhou 1
Totale 2.839
Nome #
Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. 233
The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells. 227
Expression of functional estrogen receptors in human fetal male external genitalia 225
Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs. 120
Effect of a Vitamin D3 Analogue on Keratinocyte Growth Factor-Induced Cell Proliferation in Benign Prostate Hyperplasia 117
Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells. 110
The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism 110
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. 103
Expression and biological effects of endothelin-1 in human gonadotropin-releasing hormone-secreting neurons 103
Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum. 99
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 98
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 95
Bone endothelial cells as estrogen targets. 94
Predictive Role of Pretransplant Serum CXCL10 for Cardiac Acute Rejection 90
Regenerative potential of embryonic renal multipotent progenitors in acute renal failure 89
Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue 88
Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells. 88
Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells 88
EXPRESSION AND CELLULAR LOCALIZATION OF KERATINOCYTE GROWTH FACTOR AND ITS RECEPTOR IN HUMAN HYPERPLASTIC PROSTATE TISSUE 87
Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes. 86
Human bladder as a novel target for vitamin D receptor ligands. 84
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 84
Natriuretic hormone receptors and actions on bone endothelial cells. 81
Biosynthesis of bone sialoprotein by a human osteoclast-like cell line (FLG 29.1). 80
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 80
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. 78
Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol). 74
CXCL10 release in cardiopulmonary bypass: An in vivo and in vitro study 73
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas 70
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 70
CXCL10: a candidate biomarker in transplantation. 66
Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: Modulation by peroxisome proliferator-activated receptor-gamma agonists 66
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. 61
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy 61
Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. 59
Human Benign Prostatic Hyperplasia Cells as Inducers and Targets of Chronic Immuno-mediated Inflammation. 57
Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines 52
Restorative pontential of fetal striatal multipotent progenitors in Huntington disease 17
Totale 3.563
Categoria #
all - tutte 9.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019269 0 0 0 0 0 0 0 0 0 0 144 125
2019/2020943 76 83 24 90 97 124 92 130 90 53 66 18
2020/2021552 53 36 53 50 16 75 16 58 42 81 26 46
2021/2022321 18 23 52 7 6 14 13 20 16 13 68 71
2022/2023754 66 163 38 56 52 133 92 31 71 3 16 33
2023/2024243 8 22 37 9 17 31 10 89 5 11 4 0
Totale 3.563